Fluocinonide and Cyclophosphamide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Fluocinonide (fluocinonide) and Cyclophosphamide (cyclophosphamide). Common drug interactions include acute respiratory distress syndrome among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Fluocinonide and Cyclophosphamide. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.
What is Fluocinonide?
Fluocinonide has active ingredients of fluocinonide. It is often used in eczema. eHealthMe is studying from 6,385 Fluocinonide users. Check the latest studies of Fluocinonide.
What is Cyclophosphamide?
Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.
27 people who take Fluocinonide and Cyclophosphamide together, and have interactions are studied.

What are the common drug interactions of Fluocinonide and Cyclophosphamide, by gender? *:
female:
- Acute respiratory distress syndrome
- Ascites (accumulation of fluid in the abdominal cavity)
- Atelectasis (partial or complete collapse of the lung)
- Cardiac failure
- Chest pain
- Chronic kidney disease
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
- Dizziness
- Dyspnoea (difficult or laboured respiration)
male:
- Chronic kidney disease
- Febrile neutropenia (fever with reduced white blood cells)
- Bone metabolism disorder
- Septic shock (shock due to blood infection)
- Alcoholic seizure
- Bone disorder
- Death
- Fatigue (feeling of tiredness)
- Insomnia (sleeplessness)
- Renal tubular necrosis (death of kidney tubules)
What are the common drug interactions of Fluocinonide and Cyclophosphamide, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Death
- Febrile neutropenia (fever with reduced white blood cells)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Thrombocytopenia (decrease of platelets in blood)
30-39:
- Blood cholesterol increased
- Hyperlipidaemia (presence of excess lipids in the blood)
- Obesity (having too much body fat)
- Suicide attempt
- Tardive dyskinesia (a disorder that involves involuntary movements)
- Type 2 diabetes mellitus
40-49:
- Alopecia (absence of hair from areas of the body)
50-59:
- Chronic kidney disease
- Renal tubular acidosis (medical condition that involves an accumulation of acid in the body due to a failure of the kidneys)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Emotional distress
- Pain
- Renal failure (kidney dysfunction)
- Bone metabolism disorder
- Febrile neutropenia (fever with reduced white blood cells)
- Septic shock (shock due to blood infection)
60+:
- Febrile neutropenia (fever with reduced white blood cells)
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
- Dizziness
- Dyspnoea (difficult or laboured respiration)
- Dyspnoea exertional (breathlessness or shortness of breath)
- Fall
- Generalised oedema (swelling all over the body)
- Hyperkeratosis (thickening of the outer layer of the skin)
- Hypervolaemia (abnormally increased volume of blood)
What are the existing conditions these people have? *
- Hiv Infection: 11 people, 40.74%
- Diarrhea: 4 people, 14.81%
- Itching: 3 people, 11.11%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 11.11%
- Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 11.11%
- Pain: 3 people, 11.11%
- Constipation: 2 people, 7.41%
- Cough: 2 people, 7.41%
- Cyst (a closed sac): 2 people, 7.41%
- Device Related Infection: 2 people, 7.41%
* Approximation only. Some reports may have incomplete information.
Do you take Fluocinonide and Cyclophosphamide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Fluocinonide (6,385 reports)
- Cyclophosphamide (185,240 reports)
Browse all drug interactions of Fluocinonide and Cyclophosphamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Fluocinonide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cyclophosphamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Fluocinonide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cyclophosphamide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
How the study uses the data?
The study uses data from the FDA. It is based on fluocinonide and cyclophosphamide (the active ingredients of Fluocinonide and Cyclophosphamide, respectively), and Fluocinonide and Cyclophosphamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ramipril vs. Rosuvastatin Zinc, side effect and effectiveness comparison - a second ago
- Could Lortab cause Skin Papilloma? - 3 seconds ago
- Drug interactions of Avastin and Rosuvastatin Calcium - 7 seconds ago
- Could Klonopin cause Decreased Activity? - 9 seconds ago
- High Blood Pressure and Abdominal Distension - 11 seconds ago
- Could Fentanyl cause Appetite Disorder? - 14 seconds ago
- Could Prograf cause Mood Swings? - 15 seconds ago
- Could Imbruvica cause Calculus Bladder? - 16 seconds ago
- Could Mesna cause Metastases To Lung? - 16 seconds ago
- Could Tazorac cause Inflammation? - 20 seconds ago